is toujeo a glp-1 Daily Medication Pearl: Insulin Glargine Injection (Toujeo) Toujeo for the Treatment of

A 2022 systematic review and meta-analysis published in JAMA Internal Medicine found that GLP-1 receptor agonist use was associated with increased risk of biliary disease, with an overall relative risk of approximately 1.37

That rate was much higher than among patients using the medications for Type 2 diabetes, which makes sense: Diabetes is widely understood as a chronic condition, while many people still approach weight loss medication as something temporary

[DOI] [PubMed] [Google Scholar] 88.Oshima M, Neuen BL, Jardine MJ, Bakris G, Edwards R, Levin A, et al

High prevalence of undiagnosed insulin resistance in non-diabetic subjects with Parkinsons disease

Schedule your visit today

GLP-1 Drugs and Risk for Losing Your Vision Ischemic retinopathy is a serious eye condition caused by insufficient blood flow to the retina, the light-sensitive tissue at the back of the eye